Company Filing History:
Years Active: 1999-2000
Title: The Innovations of Winfred Jettka: Pioneering Pharmaceutical Compositions
Introduction
Winfred Jettka, an innovative inventor based in Cologne, Germany, has made significant contributions to the field of pharmaceuticals. With a focus on creating effective oral compositions, Jettka's work has led to the development of two notable patents that enhance the effectiveness of antacid treatments. Her dedication to innovation demonstrates the importance of research and development in the pharmaceutical industry.
Latest Patents
Jettka holds two patents that showcase her expertise in formulating oral pharmaceutical compositions. The first patent, titled "Pharmaceutical, Orally Applicable Composition," describes a composition containing at least one antacid active substance, along with over 45% by weight of sugar and/or sugar alcohol, and between 12% and 35% by weight of water. This composition is characterized by its liquid or semisolid consistency and is substantially free of preservatives, thereby providing an effective treatment option without unnecessary additives.
The second patent, "Antacid Composition, Substantially Free of Preservatives," further reinforces her commitment to creating high-quality medications. This formulation, also of liquid to semisolid consistency, contains similar components as the first and offers substantial benefits by excluding preservatives, thus enhancing its safety and efficacy for consumers.
Career Highlights
Winfred Jettka is currently associated with Rhône-Poulenc Rorer, a renowned company in the pharmaceutical sector. Her role at the company has allowed her to contribute significantly to the field of drug formulation and innovation, aligning with her passion for improving patient outcomes through effective medications.
Collaborations
Throughout her career, Jettka has collaborated with notable professionals in the field, including Jorg-Christian Hager and Manfred Durr. These partnerships have fostered an environment of innovation, enabling the development of cutting-edge pharmaceutical products that meet the evolving needs of healthcare providers and patients alike.
Conclusion
Winfred Jettka's work exemplifies the spirit of innovation in the pharmaceutical industry. Her patents reflect a meticulous approach to creating effective and safe oral compositions that have the potential to improve the quality of life for many individuals. As she continues her work at Rhône-Poulenc Rorer, it will be exciting to see how her contributions evolve and shape the future of pharmaceutical innovations.